Between 1850 and 1937, the U.S. Pharmacopoeia listed cannabis as a medicine for more than 100 separate diseases and illnesses. But, since its removal from the U.S. Pharmacopoeia in 1937, education around medical cannabis has been largely absent in most mainstream medical, nursing and healthcare provider training curricula. Fortunately, as we know, cannabis is making a comeback, with more and more patients choosing it over prescription drugs and other over-the-counter medications. However, the gap between the patient-driven need for cannabis therapeutic support and current medical provider knowledge is immense. Seeking to better understand what’s going on, the Cannabis Center of Excellence (CCOE), Medicinal Genomics and UMass Dartmouth launched “The Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study.”